Independent Online

Sunday, May 22, 2022

Like us on FacebookFollow us on TwitterView weather by locationView market indicators

AstraZeneca's Covid-19 vaccine trials back on again

A man walks past a sign at an AstraZeneca site in Macclesfield, central England.

A man walks past a sign at an AstraZeneca site in Macclesfield, central England.

Published Sep 12, 2020

Share

London - British clinical trials for the AstraZeneca and Oxford University coronavirus vaccine have resumed following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so, the company said on Saturday.

The late-stage trials of the experimental vaccine, one of the most advanced in development, were suspended this week after an illness in a study subject in Britain.

Story continues below Advertisement

"The standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data by independent committees, and international regulators," AstraZeneca said.

"The UK committee has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume."

The company said it could not disclose further medical information.

"All trial investigators and participants will be updated with the relevant information and this will be disclosed on global clinical registries, according to the clinical trial and regulatory standards."

Related Topics:

Covid-19Health Welfare

Share